Finance & investing
Investors evaluate stocks based on metrics that are prominently reported (revenue growth, earnings per share) while neglecting to consider what is not disclosed, such as off-balance-sheet liabilities, related-party transactions, or footnoted risk factors. This leads to overconfident valuations built on incomplete financial pictures.
Medicine & diagnosis
Patients and clinicians form strong opinions about treatments based on prominently reported efficacy data while failing to notice the absence of information about side effects, contraindications, or long-term outcomes. Pharmaceutical marketing exploits this by strategically highlighting favorable attributes and omitting unfavorable ones.